Companies
Apellis Pharmaceuticals Inc (APLS) Stock: What the Analysts are Saying
The stock has a 36-month beta value of 0.94. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.